跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REZUROCK belumosudil 200 mg (as mesilate) film-coated tablets bottle - TGA Drug Approval Details
Approvals
/
TGA
/
REZUROCK belumosudil 200 mg (as mesilate) film-coated tablets bottle
Approved
STANDARD
REZUROCK belumosudil 200 mg (as mesilate) film-coated tablets bottle
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
ae7cf29d4279ea60
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ae7cf29d4279ea60
Product Name
REZUROCK belumosudil 200 mg (as mesilate) film-coated tablets bottle
Artg Id
346583
Artg Name
REZUROCK belumosudil 200 mg (as mesilate) film-coated tablets bottle
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2021-11-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/89c1d2ec3aae641480845046744a3611.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2cbd254846ad5e5db8d6c8308b19cd0d.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
ae7cf29d4279ea60
Type
Standard
Back to TGA Approvals